41 related articles for article (PubMed ID: 15048896)
1. Accelerated evolution of brain atrophy and "black holes" in MS patients with APOE-epsilon 4.
Enzinger C; Ropele S; Smith S; Strasser-Fuchs S; Poltrum B; Schmidt H; Matthews PM; Fazekas F
Ann Neurol; 2004 Apr; 55(4):563-9. PubMed ID: 15048896
[TBL] [Abstract][Full Text] [Related]
2. Lacunes are associated with late-stage multiple sclerosis comorbidities.
Zhang L; Yu X; Zheng Y; Lin A; Zhang Z; Li S; Wang N; Fu Y
Front Neurol; 2023; 14():1224748. PubMed ID: 37614972
[TBL] [Abstract][Full Text] [Related]
3. Brain atrophy in multiple sclerosis: mechanisms, clinical relevance and treatment options.
Andravizou A; Dardiotis E; Artemiadis A; Sokratous M; Siokas V; Tsouris Z; Aloizou AM; Nikolaidis I; Bakirtzis C; Tsivgoulis G; Deretzi G; Grigoriadis N; Bogdanos DP; Hadjigeorgiou GM
Auto Immun Highlights; 2019 Dec; 10(1):7. PubMed ID: 32257063
[TBL] [Abstract][Full Text] [Related]
4. Apolipoprotein E polymorphism and the risk of aneurysmal subarachnoid hemorrhage in a South Indian population.
Suvatha A; Kandi SM; Bhat DI; Rao N; Vazhayil V; Kasturirangan CG
Cell Mol Biol Lett; 2017; 22():25. PubMed ID: 29213291
[TBL] [Abstract][Full Text] [Related]
5. HIV, Tat and dopamine transmission.
Gaskill PJ; Miller DR; Gamble-George J; Yano H; Khoshbouei H
Neurobiol Dis; 2017 Sep; 105():51-73. PubMed ID: 28457951
[TBL] [Abstract][Full Text] [Related]
6. Brain MRI atrophy quantification in MS: From methods to clinical application.
Rocca MA; Battaglini M; Benedict RH; De Stefano N; Geurts JJ; Henry RG; Horsfield MA; Jenkinson M; Pagani E; Filippi M
Neurology; 2017 Jan; 88(4):403-413. PubMed ID: 27986875
[TBL] [Abstract][Full Text] [Related]
7. An MRI-defined measure of cerebral lesion severity to assess therapeutic effects in multiple sclerosis.
Kim G; Tauhid S; Dupuy SL; Tummala S; Khalid F; Healy BC; Bakshi R
J Neurol; 2016 Mar; 263(3):531-8. PubMed ID: 26754005
[TBL] [Abstract][Full Text] [Related]
8. T1- Thresholds in Black Holes Increase Clinical-Radiological Correlation in Multiple Sclerosis Patients.
Thaler C; Faizy T; Sedlacik J; Holst B; Stellmann JP; Young KL; Heesen C; Fiehler J; Siemonsen S
PLoS One; 2015; 10(12):e0144693. PubMed ID: 26659852
[TBL] [Abstract][Full Text] [Related]
9. Why AMD is a disease of ageing and not of development: mechanisms and insights.
Sharma K; Sharma NK; Anand A
Front Aging Neurosci; 2014; 6():151. PubMed ID: 25071560
[TBL] [Abstract][Full Text] [Related]
10. Structural and metabolic damage in brains of patients with SPG11-related spastic paraplegia as detected by quantitative MRI.
Stromillo ML; Malandrini A; Dotti MT; Battaglini M; Borgogni F; Tessa A; Storti E; Denora PS; Santorelli FM; Gaudiano C; Battisti C; Federico A; De Stefano N
J Neurol; 2011 Dec; 258(12):2240-7. PubMed ID: 21625935
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for and management of cognitive dysfunction in multiple sclerosis.
Benedict RH; Zivadinov R
Nat Rev Neurol; 2011 May; 7(6):332-42. PubMed ID: 21556031
[TBL] [Abstract][Full Text] [Related]
12. The immune-modulatory role of apolipoprotein E with emphasis on multiple sclerosis and experimental autoimmune encephalomyelitis.
Zhang HL; Wu J; Zhu J
Clin Dev Immunol; 2010; 2010():186813. PubMed ID: 20613949
[TBL] [Abstract][Full Text] [Related]
13. Multiple sclerosis in the elderly patient.
Awad A; Stüve O
Drugs Aging; 2010 Apr; 27(4):283-94. PubMed ID: 20359260
[TBL] [Abstract][Full Text] [Related]
14. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).
Ramkumar HL; Zhang J; Chan CC
Prog Retin Eye Res; 2010 May; 29(3):169-90. PubMed ID: 20206286
[TBL] [Abstract][Full Text] [Related]
15. Reduced physiological complexity in robust elderly adults with the APOE epsilon4 allele.
Cheng D; Tsai SJ; Hong CJ; Yang AC
PLoS One; 2009 Nov; 4(11):e7733. PubMed ID: 19890394
[TBL] [Abstract][Full Text] [Related]
16. Disease biomarkers in multiple sclerosis: potential for use in therapeutic decision making.
Harris VK; Sadiq SA
Mol Diagn Ther; 2009; 13(4):225-44. PubMed ID: 19712003
[TBL] [Abstract][Full Text] [Related]
17. Impact of apolipoprotein E (ApoE) polymorphism on brain ApoE levels.
Riddell DR; Zhou H; Atchison K; Warwick HK; Atkinson PJ; Jefferson J; Xu L; Aschmies S; Kirksey Y; Hu Y; Wagner E; Parratt A; Xu J; Li Z; Zaleska MM; Jacobsen JS; Pangalos MN; Reinhart PH
J Neurosci; 2008 Nov; 28(45):11445-53. PubMed ID: 18987181
[TBL] [Abstract][Full Text] [Related]
18. Identification of differentially expressed proteins in experimental autoimmune encephalomyelitis (EAE) by proteomic analysis of the spinal cord.
Liu T; Donahue KC; Hu J; Kurnellas MP; Grant JE; Li H; Elkabes S
J Proteome Res; 2007 Jul; 6(7):2565-75. PubMed ID: 17571869
[TBL] [Abstract][Full Text] [Related]
19. Apolipoprotein E isoform-dependent dendritic recovery of hippocampal neurons following activation of innate immunity.
Maezawa I; Zaja-Milatovic S; Milatovic D; Stephen C; Sokal I; Maeda N; Montine TJ; Montine KS
J Neuroinflammation; 2006 Aug; 3():21. PubMed ID: 16934151
[TBL] [Abstract][Full Text] [Related]
20. Apolipoprotein E-specific innate immune response in astrocytes from targeted replacement mice.
Maezawa I; Maeda N; Montine TJ; Montine KS
J Neuroinflammation; 2006 Apr; 3():10. PubMed ID: 16603079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
